Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Ovarian Neoplasms 10Peritoneal Neoplasms 4Endometrial Neoplasms 4Uterine Cervical Neoplasms 3Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Carcinoma, Ovarian Epithelial 2Uterine Neoplasms 1Ovarian Cysts 1Obesity, Morbid 1Genital Neoplasms, Female 1Genital Diseases, Female 1Endometrial Adenocarcinoma 1Cholangiocarcinoma 1Breast Neoplasms 1Appendiceal Neoplasms 1Adnexal Diseases 1

Interventions

Taxes 5Paclitaxel 5Carboplatin 4Cisplatin 3Immunoglobulin G 2Doxorubicin 2Disulfides 2Bevacizumab 2trastuzumab biosimilar HLX02 1trametinib 1temsirolimus 1pegfilgrastim 1nintedanib 1linrodostat 1ixabepilone 1cediranib 1brivanib 1Trastuzumab 1Sunitinib 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Platinum 1PF-05280014 1Ontruzant 1Ogivri 1Nivolumab 1Metformin 1Medroxyprogesterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Adenocarcinoma × Laparoscopy × Gynecologic × Clear all
NCT00002706 2015-05-29

Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus

GOG Foundation

Phase 3 Completed
2,616 enrolled
GynecologicSarcoma

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡